CRISPR Therapeutics Statistics
NASDAQ: CRSPHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
52.35-1.65 (-3.06%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 52.05 -0.57%
CRISPR Therapeutics by the numbers
CRISPR Therapeutics has a market capitalization of $5.06 billion based on 96.69M shares outstanding. With trailing EPS of $-4.74, CRISPR Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.4% below its 50-day average and 1.8% below its 200-day average.
Average daily trading volume is 1.59M shares, or about $83.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CRSP valuation vs. peer median
| Metric | CRSP | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.06B | $4.67B | +8% |
| Avg. volume | 1.59M | 1.74M | -8% |
Peer median across 8 companies: SRRK, KOD, IOVA, ADPT, RLAY, IMVT, TARS, BEAM.
Valuation
- Market cap
- $5.06B
- Price / sales (latest FY)
- 1,442.13
- EPS (TTM)
- $-4.74
- Shares outstanding
- 96.69M
Price and trading
- Previous close
- 54.00
- Open
- 53.00
- Day range
- 52.27 – 54.59
- 52-week range
- 44.12 – 78.38
- 52-week change
- -25.87%
- Beta
- —
- Volume
- 1.68M
- Average volume
- 1.59M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 3, 2026
Additional statistics
- Market Cap
- 5.06B
- Forward Pe
- -14.97
- Eps
- -4.74
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 78.38
- Week52 Low
- 44.12
- Avg Volume
- 1.59M
- Shares Outstanding
- 96.69M
- Ma50
- 54.73
- Ma200
- 53.29
- Earnings Date
- Aug 3, 2026
- Pct From52w High
- -33.21%
- Pct From52w Low
- 18.65%